4 research outputs found
Selection of Endogenous Control Reference Genes for Studies on Type 1 or Type 2 Endometrial Cancer.
A panel of 32 candidate reference genes was used to identify the most stable genes for gene normalisation in quantitative RT-PCR studies using endometrial biopsies obtained from women with endometrial cancer (type 1 or type 2) and without cancer (controls). RNA from the biopsies was isolated, examined for purity and quality, and then reverse transcribed into cDNA before being subjected to real-time qRT-PCR analysis in triplicate within the TaqMan gene Expression Assay kit. The most 'stable' endogenous control genes were then identified using the geNorm qbase + 2 and NormFinder software packages. PSMC4, PUM1 and IPO8 were identified as the best reference genes combination for type 1 endometrial cancer (grades 1, 2 and 3), whereas for type 2 endometrial cancer (serous and carcinosarcoma), UBC, MRPL19, PGK1 and PPIA were the best reference genes combination. We conclude that the use of these normaliser combinations should provide accurate interpretation of gene expression at the transcript level in endometrial cancer studies especially for types 1 and 2 cancers
Prediction of preterm labour from a single blood test: The role of the endocannabinoid system in predicting preterm birth in high-risk women
Objective: To determine if plasma concentrations of the N-acylethanolamines (NAEs) N-arachidonoylethanolamine (AEA), N-oleoylethanolamide (OEA) and N-palmitoylethanolamide (PEA) increase in women at high risk for preterm birth (PTB) and whether these could be used to predict preterm delivery and if so, how they compare with current methods. Design: Prospective cohort study. Setting: A large UK teaching hospital. Population: 217 pregnant women were recruited between 24 and 34 gestational weeks at ‘high-risk’ for PTB, recruited from a prematurity prevention clinic or antenatal wards. Methods: Plasma AEA, OEA, and PEA concentrations were measured using ultra-high performance liquid chromatography-tandem mass spectrometry whilst FAAH enzyme activity was measured by fluorometric radiometric assay and CL by ultrasound scan. The clinical usefulness of these measurements were determined by ROC and multivariate analyses. Results: AEA and PEA concentrations were significantly higher in women who delivered prematurely. An AEA concentration >1.095 nM predicted PTB, the gestational age at delivery and the recruitment to delivery interval (RTDI). A PEA concentration >17.50 nM only predicted PTB; FAAH enzyme activity was not related to these changes. Multivariate analysis (all variables) generated an equation to accurately predict the RTDI. Conclusions: A single plasma AEA or PEA measurement can predict PTB. A single AEA measurement predicts the gestational age of delivery and the remaining period of pregnancy with reasonable accuracy and better than existing conventional tests thus offering a better window for primary prevention of PTB
(Endo)Cannabinoids and Gynaecological Cancers
Gynaecological cancers can be primary neoplasms, originating either from the reproductive tract or the products of conception, or secondary neoplasms, representative of metastatic disease. For some of these cancers, the exact causes are unknown; however, it is recognised that the precise aetiopathogeneses for most are multifactorial and include exogenous (such as diet) and endogenous factors (such as genetic predisposition), which mutually interact in a complex manner. One factor that has been recognised to be involved in the pathogenesis and progression of gynaecological cancers is the endocannabinoid system (ECS). The ECS consists of endocannabinoids (bioactive lipids), their receptors, and metabolic enzymes responsible for their synthesis and degradation. In this review, the impact of plant-derived (Cannabis species) cannabinoids and endocannabinoids on gynaecological cancers will be discussed within the context of the complexity of the proteins that bind, transport, and metabolise these compounds in reproductive and other tissues. In particular, the potential of endocannabinoids, their receptors, and metabolic enzymes as biomarkers of specific cancers, such as those of the endometrium, will be addressed. Additionally, the therapeutic potential of targeting selected elements of the ECS as new action points for the development of innovative drugs will be presented
Expression and Function of the Endocannabinoid Modulating Enzymes Fatty Acid Amide Hydrolase and N-Acylphosphatidylethanolamine-Specific Phospholipase D in Endometrial Carcinoma
Background:
The concentrations of three N-acylethanolamines (NAEs), anandamide (AEA),
N-oleoylethanolamide (OEA), and N-palmitylethanolamide (PEA) are increased in
the endometria of women with endometrial cancer (EC). It is widely accepted
that plasma levels of these three NAEs are regulated by the actions of the
rate-limiting enzymes N-acylphoshatidylethanolamine-specific phospholipase D
(NAPE-PLD) and fatty acid amide hydrolase (FAAH), which are synthesizing and
degradative, respectively. The expression and activity of these enzymes have
not previously been studied in EC.
Methods:
FAAH activity in peripheral blood lymphocytes, and transcript and protein
expression for FAAH and NAPE-PLD in EC tissues were measured using enzyme,
quantitative RT-PCR, and histomorphometry (of immunoreactive tissue sections),
respectively. Samples were from 6 post-menopausal women with atrophic
endometria (controls) and 34 women with histologically diagnosed EC.
Concentrations of the three NAEs also measured in plasma and tissues were
correlated with lymphocytic FAAH activity and the NAPE-PLD and FAAH transcript
and protein levels.
Results:
Peripheral lymphocyte FAAH activity was unaffected in women with EC compared to
controls. The FAAH transcript expression level was significantly (p <
0.0001) 75% lower in EC whilst NAPE-PLD levels were not significantly (p =
0.798) increased. In line with the transcript data, a significant (p <
0.0001) tumor type-dependent 70–90% decrease in FAAH protein and significant 4-
to 14-fold increase in NAPE-PLD protein (p < 0.0001) was observed in the
malignant tissue with more advanced disease having lower FAAH and higher
NAPE-PLD expression than less advanced disease. Correlation analyses also confirmed
that tissue NAE concentrations were inversely related to FAAH expression and
directly correlated to NAPE-PLD expression and the NAPE-PLD/FAAH ratio.
Conclusion:
These data support our previous observation of tissue levels of AEA, OEA, and
PEA and a role for NAE metabolism in the pathogenesis of EC.</p